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72. ABSTRACT
The aim of the study was to develop and study a primary screening process that would be linked to
the targeted isolation using a computer-assisted scaling-up of separation method. The primary
screening would be based on analytical HPLC gradient separation and microtitre plate scale 
bioassays.
The ability of using the computer-assisted simulation programme DryLab to simulate reversed
phase TLC separations was successfully demonstrated by simulating the separation of phenolic
compounds on the basis of the information obtained from initial TLC separations. It was also
concluded that the transfer of the method from TLC to HPLC is possible by means of DryLab.
However, this requires a relatively large number of experiments in order to be able to predict to a 
reasonably accurate degree, the separations after the transfer procedure. 
The ability to use DryLab for scaling-up a separation was tested by simulating a preparative LC
separation of phenolic compounds based on the information from analytical initial runs. The
developed scaling-up procedure was also applied to plant extracts. Comparison of the retention
times of simulated and real separations of onion extracts demonstrates that the simulation and the
real separation are practically the same with respect to the peaks of interest. The scaling-up
procedure was also applied to the separation of the bioactive components in Cladina stellaris. Also
in this case, the DryLab-assisted scaling-up procedure was found to considerably enhance the
isolation of active compounds. The scaling-up process was found to require the same preliminary
experiments that would have been needed to optimize the analytical-scale elution. The information
from the analytical full-scale gradient separations in the fractionations can be used for scaling-up
purposes.
The computer-assisted simulation program was a convenient tool for scaling-up a separation method
from analytical to preparative scale. Under optimum conditions only three runs are required, two
initial runs in HPLC and an actual preparative separation. If a good preparative separation can be
simulated in DryLab then a good preparative separation will be achieved in practise. The separation
is predicted in most cases with sufficient accuracy. However, it may sometimes be necessary to 
carry out at least one test separation at the preparative scale in order to check the retention times.
A microfractionation procedure was developed in which the sample extract was fractionated into a 
microwell plate using HPLC full-scale gradient separation, and chemical- and cell-based bioactivity
tests applied to this assay platform. The radical scavenging assay was successfully applied on the
8microplate and, when combined with microfractionation it seemed to be a useful chemical assay for 
primary screening. In order to combine the microfrationation procedure with a cell-based assay, the
antimicrobial activity of a reference solution and two plant extracts was studied by adding the
microbial cells to fractionated and lyophilized microplate wells. In the antimicrobial test it was
possible to identify precisely active peaks, and no further fractionations or separation optimizations
were subsequently required. The automated 45Ca2+ uptake assay was also successfully coupled with
HPLC microfractionation for the primary screening of calcium antagonistic components in complex
matrices. The procedure was shown to reduce significantly the time needed for bioassay-guided
isolation of active compounds from a root extract of Peucedanum palustre.
In conclusion this study has gathered together the pieces and information needed to build up and 
develop at the laboratory scale a primary screening procedure from microfractionation, via the
appropriate bioassay to the isolation of bioactive compounds using computer-assisted separation
method development.
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4. LIST OF ABBREVIATIONS 
? retention value 
%B strong solvent in a mobile phase (% v/v) 
DPPH 2,2-diphenyl-1-picrylhydrazyl 
FTIR fourier-transform infrared spectroscopy 
HPLC high performance liquid chromatography 
HTS high-throughput screening 
k'c capacity factor of column liquid chromatography 
k'p retention value for planar chromatography comparable to k'c 
LC liquid chromatography 
MPLC medium pressure liquid chromatography 
MS mass spectrometry 
N plate number 
NMR nuclear magnetic resonance spectroscopy 
Rf retardation factor 
RP reversed-phase 
TLC thin-layer chromatography 
UV ultraviolet 
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5. INTRODUCTION
Over the centuries the world’s population exclusively used medicinal plants as therapeutic agents.
Today, in spite of the exponential development of synthetic pharmaceutical chemistry, natural
products still play a dominant role in the discovery of leads for the development of drugs for the 
treatment of human diseases (NEWMAN et al. 2003). Among the estimated 420,000 plant species 
on earth (BRAMWELL 2002), only a small percentage has been phytochemically investigated.
Moreover, a plant extract may contain several thousand different secondary metabolites but
phytochemical analysis will reveal only a narrow spectrum of its constituents. The plant kingdom
thus represents an enormous reservoir of pharmacologically valuable molecules still waiting to be
discovered (HOSTETTMANN et al. 1998; HOSTETTMANN et al. 2000; VERPOORTE et al. 
2000).
Searching for new drugs in plants implies the screening of extracts for the presence of novel
compounds and investigation of their biological activities. The path that leads from an intact plant to 
its pure constituent is long and the work may last from weeks to years. This work includes
collection of the plant material, identification of the species by a botanist, extraction using different
solvents, followed by the analysis of the extracts by different chromatographic methods,
fractionation and isolation steps using different preparative chromatographic techniques, structure
elucidation of the constituents by a combination of various spectroscopic and chemical methods,
pharmacological and toxicological testing, synthesis or semi-synthesis of the natural product, and
the synthesis of analogues with the aim of establishing structure-activity relationship
(HOSTETTMANN et al. 2001). This procedure often involves biological screening followed by
activity-guided fractionation. Simple and inexpensive in vitro bioassays have been introduced in
laboratories for the rapid screening of crude plant extracts. Bioassays also serve as a guide during
the isolation process, where fractions are biologically evaluated and those continuing to exhibit
activity are carried through further isolation and purification steps until pure active principles are 
obtained (HOSTETTMANN and WOLFENDER 1997; KINGHORN et al. 2003). 
Development and optimization of the chromatographic methods used in the drug discovery process
for analysis and fractionation can be laborious and time consuming. To simplify and accelerate this 
part of the process, several computer simulation softwares and expert systems have been introduced.
With a limited number of experimental runs, chromatographers can model changes in experimental
conditions, optimize method conditions and predict method robustness. By using this kind of
computer simulation program, such as DryLab, it is possible to save time and money and to develop
12
more reliable and robust chromatographic methods (BACZEK et al. 2001; HOANG et al. 2003;
MOLNAR 2002).
When the whole sample, e.g. a plant extract, has proved to be biologically active it is necessary to
isolate the pure constituents that are responsible for the activity. The isolated constituents can be
used for structure elucidation, further bioassays, structural modifications, for studying the mode of
action of the compounds, their side effects, toxicology etc. (HOSTETTMANN et al. 1991). 
Different kinds of chromatographic techniques are used to isolate and purify the natural products.
Especially preparative liquid column chromatography techniques, including preparative HPLC
(high performance liquid chromatography) and MPLC (medium pressure liquid chromatography)
techniques, play an important role in the isolation processes. A productive, preparative-scale
separation can be obtained in most cases by scaling-up an optimized analytical scale separation
(HOSTETTMANN et al. 1997).
Tracking and isolating the process of obtaining bioactive compounds from natural products is a 
challenge which needs new innovations in order to become more rapid, more effective and less
expensive. One new approach to this challenge is HPLC-based activity profiling. This concept
combines analytical HPLC separation with modern miniaturized bioassays and on-line
spectroscopy. It also provides a good basis for the isolation of active compounds (HAMBURGER
2003). By developing techniques for the primary screening and by linking the isolation process
more closely to the activity, it is possible to develop an efficient tool for drug discovery.
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6. REVIEW OF THE LITERATURE 
6.1. Preparative liquid chromatography
Chromatography is fundamentally a preparative technique. Analytical chromatography made its
debut when advances in instrumentation technology allowed analysts to continuously monitor the
column effluent. The basic difference between analytical and preparative chromatography is not the
quantity of sample to be separated, but the purpose of the separation and the nature of the
information obtained (GUIOCHON and KATTI 1987). Analytical chromatography aims at
separating complex mixtures in order to identify and quantitize the components of mixtures. The
purpose of analytical chromatography is to achieve rapid determination of the structure of the
component through the direct acquisition of proper information, and calculation of its concentration
through calibration of the detector signal (GUIOCHON 2002). Preparative chromatography aims at 
isolating a certain amount of purified component and using the material for further goals.
Depending on the amount required preparative chromatography can be viewed from two different
perspectives. The isolation can be carried out at a laboratory-scale when the isolated compounds are
used for research and development purposes, e.g. for off-line spectral analysis or for the
determination of the bioactivity. In laboratory-scale preparative chromatography the amount of
isolated compounds varies from milligrams (maybe even micrograms) to a few grams. Preparative
LC (liquid chromatography) in the laboratory often deals with difficult separations of unknown
compounds and more than one or two products are required. In industrial-scale or process-scale
preparative chromatography the aim is often to isolate one or two pure compounds for commercial
purposes and the method is expected to produce amounts ranging from hundreds of grams to
hundreds of kilograms of pure substance (PORSCH 1994; GUIOCHON 2002). However, there are
some concerns that are identical in preparative chromatography regardless of the scale, e.g. the need
to produce as concentrated a fraction as possible, to collect and transfer the fraction without
contamination, and to perform the separation as quickly and cheaply as possible. The costs of the
method may vary considerably depending on whether the separation is made once or on a routine
basis, and at a low or a high production level (GUIOCHON and KATTI 1987; GUIOCHON 2002).
Small amounts of pure product can be recovered by analytical HPLC methods. When larger
amounts of a fraction are to be separated from a complex mixture for further use, then it is necessary
to inject a larger amount of sample than in analytical separation and/or to repeat the injections and
pool the product fractions. When the sample load is increased it is clear that the retention times,
band profiles and hence the recovery yield and production rate depend strongly on the sample size
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and concentration of the sample. The amount of compound adsorbed on or dissolved in the
stationary phase, at equilibrium with a certain concentration in the mobile phase, depends on its 
concentration, and on the nature and the concentration of all the other components locally present,
be they mobile phase additives or sample components eluted close to the component concerned.
When the sample load is increased enough, the chromatographic behavior of the compounds
changes from linear to non-linear. In non-linear chromatography, where retention mechanisms are 
never linear nor independent, chromatograms are no longer a series of well-resolved Gaussian-
shaped peaks and the complex assemblies of peaks change shape and appear to interact with their
neighbors when the sample size is increased (SNYDER et al. 1997; GUIOCHON 2002).
For complex mixtures of components that exhibit a board range of retentivity, like natural product
extracts, the use of gradient elution allows the separation of the whole sample in a single run.
Preparative gradient elution is especially attractive for laboratory-scale separations where the
objective is normally to obtain a certain amount of product with a specific purity, within a certain 
recovery ratio limitation with the expenditure of both minimum time (i.e. achieving maximum
production rate) and development effort, with given equipment and without cost consideration
(CRÉTIER and ROCCA 1994). A number of experimental variables have an effect on the
preparative separation of a binary mixture by gradient elution in reversed-phase chromatography.
Theoretical models allowing the simulation of a preparative gradient elution have been developed
for studying the effect of the experimental variables (EBLE et al. 1987; SNYDER et al. 1988; COX 
et al. 1988; ANTIA and HORVÁTH 1989, COX et al. 1989; SNYDER et al. 1988a; SNYDER et al.
1989b; SNYDER et al. 1991; CRÉTIER et al. 1992; HU et al. 1992; GOLSHAN-SHIRAZI and
GUIOCHON 1994; FELINGER and GUIOCHON 1996a; GRITTI and GUIOCHON 2004;
MARCHETTI et al. 2005). Most of these theoretical models are based on linear solvent strength 
theory (SNYDER and DOLAN 1998) and assume the competitive Langmuir isotherm
(LANGMUIR 1916). Studies have also been carried out on the optimization of preparative gradient
elution chromatography when deviations from the linear solvent strength theory occur (JANDERA
et al. 1997; GRITTI et al. 2003), and when the Langmuir isotherm is no longer suitable (FALLAH
and GUIOCHON 1991). The use of these models requires efficient numerical techniques and they
are rarely convenient tools in practical preparative chromatography. The investigations performed
using simulations based on theoretical models provide an interesting insight into the phenomena
under overload conditions, and the derived conclusions can be considered as useful guidelines for
the selection of the best experimental conditions in preparative gradient elution reversed-phase
liquid chromatography (CRÉTIER and ROCCA 1994).
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The optimum operating conditions in overloaded gradient elution are very similar to those used in 
isocratic overloaded elution (SNYDER et al. 1991). However, there are some noteworthy features
that come to light when comparing gradient and isocratic elution under overloaded conditions. The
main difference in chromatograms obtained with isocratic vs. gradient elution is in the shape of the
band shape as the sample weight increases. Isocratic separation yields right-triangle shaped bands,
whereas gradient elution results in “shark-fin” shaped bands (SNYDER et al. 1997). The volume of 
solvent required to wash and regenerate the column after a separation is usually larger in gradient
elution than in isocratic elution (FELINGER and GUIOCHON 1998). The recovery yield achieved
under optimum conditions is the same in gradient and in isocratic elution, but the optimum loading
factor is higher in gradient elution because band compression diminishes the tag-along effect of the
more strongly retained component. The average concentration of the collected fractions and the
production rate are therefore higher in the gradient mode (FELINGER and GUIOCHON 1996c;
FELINGER and GUIOCHON 1998). The sample solubility may be a problem with gradient elution,
where it is essential to use relatively weak sample solvents (SNYDER et al. 1997). In gradient
elution there is no need for high column efficiency because the average retention factor is higher
than the optimum value during separation and the steepness of the optimum gradient is primarily
dependent on the elution order. Gradient steepness should be higher for purification of the less
strongly retained component than for the more strongly retained one (FELINGER and GUIOCHON
1996a; FELINGER and GUIOCHON 1998).
6.1.1. Method development
Laboratory-scale preparative LC of an unknown compound represents a typical situation in which
the selection of proper conditions is a trial-and-error procedure based on experience in the field and
on the information about corresponding analytical separation (PORSCH 1994). Some specific 
considerations that should be kept in mind when developing a preparative reversed-phase HPLC
method have been listed by SNYDER et al. (1997). In preparative chromatography it is necessary to 
be able to remove the mobile phase from the collected fraction. Hence, all the eluent components
including buffers must be volatile. The buffers preferred in preparative LC include acetic or formic
acid, formate, or acetate. In contrast to analyses in which the goal is baseline separation for all the
compounds in preparative chromatography it is necessary to achieve the largest reasonable 
resolution of the product band from adjacent impurity bands, which means especially large values of 
?. Large values of ? for the product band are extremely advantageous in preparative LC because
they allow much larger sample weights. One important consideration in preparative chromatography
is the solubility of the sample in the mobile phase. The maximum amount recovered is obtained for 
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specific injection conditions (CRÉTIER et al. 1992). In preparative LC, it desirable to inject a large
weight of sample dissolved in a relatively small volume of mobile phase. To avoid problems, it is
advisable to select a phase system that has sufficient sample solubility as this determines the
possible loading, the performance, the throughput of the system and the concentration of the
collected fractions. Usually the best and the simplest alternative is to use the mobile phase as the
sample solvent, but unfortunately this is not always feasible in practice. The critical properties of the 
solvents for the sample are the viscosity of the concentrated sample solution in the mobile phase,
and the elution strength of the sample solvent compared to the mobile phase (PORSCH 1994).
Differences in viscosity between the sample solution and mobile phase may induce a distortion of
the flow profile, which can cause tailing if the sample viscosity is high (KNOX and PYPER 1986;
CZOK et al. 1991) or fronting if the viscosity is much lower than that of the mobile phase
(PORSCH 1994). The sample solvent may have deleterious effects on the chromatographic
performance if the solvent is stronger than the eluent (JANDERA and GUIOCHON 1991).
Therefore, anomalous peaks may occur even when the sample solubility in the mobile phase is 
sufficient if the sample solvent and mobile phase differ considerably in viscosity and/or the elution
power of the sample solvent substantially exceeds the mobile phase strength (PORSCH 1993).
Especially with gradient elutions it is essential to use low solvent strengths to allow high sample
loads (COX and SNYDER 1992). One important consideration in preparative LC is also the relative
importance of N and ?. When the column overload increases, the sample band widths start to 
increase and the column plate number becomes more a function of sample size than of the column
conditions. As a result, it is often advantageous in preparative LC to use larger particles than is the
case for analytical separation. Larger particles have higher loadability and cheaper price than
smaller particles, they cause lower back-pressure compared to smaller particles allowing increasing
the flow rate that decreases the elution time (SNYDER et al. 1997). On the other hand, high column
efficiency sharpens the peak edges, maximizes the displacement effect and minimizes the tag-along
effect. In tag-along effect major peak distorts the following minor peak by pulling minor peak
toward major peak (SNYDER et al. 1997). Because of the significant reduction of the tag-along
effect with increasing theoretical plate number, the optimum injection concentration for
major/minor mixtures is an increasing function of column efficiency (CRÉTIER et al. 1992;
CRÉTIER and ROCCA 1994).
Any method development and optimization problem begins by the selection of the objective
function and for the preparative HPLC in laboratory scale it is the production rate (GUIOCHON
2002) or the product of the production rate and recovery yield (FELINGER and GUIOCHON
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1998). The critical parameters that have an effect on the functions in gradient elution are the
gradient steepness, loading factor and column efficiency (FELINGER and GUIOCHON 1994;
FELINGER and GUIOCHON 1998). The production rate in preparative gradient elution HPLC
depends more on the initial concentration of the stronger eluent than on the steepness of the gradient
(JANDERA et al. 1997), and the gradient retention factor has proven to be a more significant factor
than gradient steepness (FELINGER and GUIOCHON 1998). The performance of gradient elution
is the most sensitive to changes in the retention factor. A significant loss of production rate will 
occur if the gradient steepness is not high enough and the value of the retention factor is outside the
range (FELINGER and GUIOCHON 1998). The optimum gradient steepness is completely
different for compounds with different separation factors and it depends very much on whether the
solutes are parallel, divergent or convergent (FELINGER and GUIOCHON 1996a; FELINGER and
GUIOCHON 1996b) The factors that affect the loading capacity of the column in preparative
gradient elution are the displacement and tag-along effects (CRETIER and ROCCA 1994). The
production rate can increase under conditions of a predominant displacement effect or decrease
under conditions with a predominant tag-along effect, because of competition between the mixture
components for interaction with the stationary phase (GOLSHAN-SHIRAZI and GUIOCHON
1990). The loading factor and the production rate are also affected by column characteristics, and 
the flow rate and column pressure (GOLSHAN-SHIRAZI and GUIOCHON 1990; GUIOCHON
2002; LIU et al. 2003). The most important properties of preparative columns, such as selectivity,
efficiency, loadability, scalability and recovery, have been summarized by MAJORS (2004). The
maximum production rate can be achieved when the column is operated at a high mobile phase flow
velocity, and a column with optimum characteristics is used (GOLSHAN-SHIRAZI and
GUIOCHON 1989; GUIOCHON 2002). Increasing the average column pressure is an efficient way 
to increase the production rate in preparative chromatography, especially with larger molecules like
proteins (LIU et al. 2003). The pressure has been found to affect retention factors, chiral selectivity
and column efficiency in different LC systems (MCGUFFIN and EVANS 1991; GUIOCHON and
SEPANIAK 1992; RINGO and EVANS 1997).
One traditional approach to method development for reversed-phase HPLC preparative separation in
laboratory scale has been presented by SNYDER and co-workers (SNYDER et al. 1989a; SNYDER
et al. 1989b). They showed that there is general parallelism among isocratic and gradient modes
under lightly overloaded (i.e. touching band) and heavily overloaded (i.e. overlapping band)
conditions and that these modes correspond to small-sample separations. The first step is to adjust
the eluent composition and column properties in order to maximize the selectivity between the 
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product band and adjacent impurity bands by carrying out the necessary number of initial runs with
a small sample. The next step is to run initial wide-range gradients in order to estimate suitable
values of initial and final %B in the gradient, the gradient times for two additional exploratory runs
and the flow rate. The next two additional small-sample runs, in which only the gradient time varies
within the recommended gradient range should be run to define separation as a function of the
gradient conditions and column dimensions. The next step is to estimate the column capacity and 
loadability of the sample in question by carrying out a run under the selected conditions with a
larger sample which appreciably increases the band width. It is possible, based on all the initial
experiments, to calculate the sample size and production rate for touching bands as a function of the
gradient time and column conditions. Finally, the calculations are compared to the experimental
results and the conditions are fine-tuned if necessary.
6.1.2. Method scaling-up
Preparative HPLC separations are derived from the kinetic and thermodynamic conditions
established on a small scale, such as in analytical runs (MAZZEI and D’AVILA 2003). When the
separations need to be carried out in larger columns than in the analytical separations, the methods
need to be scaled-up. HPLC method scaling-up is often performed on the basis of trial-and-error by
means of experiments (PAVLI et al. 2004; MANT and HODGES 2002), but it can also be
performed by using a direct scaling-up method based on the factor calculated from the proportion of
the column lengths and cross-sectional areas of the preparative to analytical columns. Direct 
scaling-up has been used in both isocratic (HEUER et al. 1996) and gradient modes (APERS et al.
1998). The scaling-up process can be made easier if the packing material is the same or at least from
the same batch or manufacturing process as that used in analytical and preparative scales (MAJORS
2004). Scaling-up can also be based on mathematical models, like the general rate model (GU et al. 
1992), for describing the chromatographic phenomena. Mathematical models have proved to be a
practical tool for the scaling-up of the semi-preparative isocratic separation of a multicomponent
mixture of low molecular weight compounds (MAZZEI and D’AVILA 2003). Some experimental
cases using peptide and protein samples have demonstrated the possibility of applying mathematical
models to the scaling-up of gradient elution chromatography (GU and ZHENG 1999;
KALTENBRUNNER et al. 1997).
In certain cases, TLC (thin layer chromatography) analysis of the sample can be used as a first
indication of the correct operating conditions for preparative HPLC separation (HOSTETTMANN 
et al. 1997). Thin layer chromatography has traditionally been considered as a pilot technique for
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high performance liquid chromatography. TLC has also been considered to be a suitable pilot
technique for solvent or sorbent optimization because it is more flexible, more rapid and cheaper
than column techniques (GEISS 1987). With TLC, several phase systems can be checked at the
same time without having to use expensive apparatus. Additionally, it is possible to optimize the
developing solvent system by using a Vario chamber (Camag, Switzerland), which enables
simultaneous, side-by-side development with six different solvents on the same TLC plate. Identical
or at least comparable mobile and stationary phases can also be used in TLC and HPLC and
determination of irreversible adsorption in the case of HPLC is possible with the help of TLC
(REUKE and HAUCK 1995). However, there are some prerequisites for a successful method
transfer: similar sorbents, identical composition of the mobile phase, and adherence to reproducible
chromatographic conditions in TLC and HPLC (REUKE and HAUCK 1995).
The use of planar chromatography for the initial optimization of solute retention in column
chromatography is associated with some fundamental factors. The differences between the two 
techniques, e.g. solvent demixing, preadsorbtion, phase ratio gradient etc., need to be taken into
account when TLC and HPLC separations are compared. These so-called “thin layer effects” make
it difficult to achieve complete equivalency between TLC and HPLC (RÓZYLO and JANICKA
1991). The comparability of the methods is often very case-specific, and may depend on the type of
chambers used in TLC, the nature of the mobile phase or the properties of the solute (RÓZYLO and
JANICKA 1991). However, it has been concluded in several articles that reversed-phase TLC and
HPLC methods are comparable and it is possible to predict the separation in HPLC based on
information from TLC (ISSAQ et al. 1978; GOLKIEWICZ 1981a; GOLKIEWICZ 1981b; JOST et 
al. 1984; GEISS 1987; REUKE and HAUCK 1995; KISS et al. 2000). These observations suggest
that computer-assisted optimization programs, which have been created for the purpose of
developing column chromatographic methods, can also be applied in the optimization of TLC
separations.
6.1.3. Computer-simulated HPLC separation
A major challenge in the development of chromatographic separation methods is the rational
selection of optimal experimental conditions that can provide an adequate resolution within a
reasonable time. To simplify and accelerate the optimization process, several computer simulation
softwares have been introduced (SCHMIDT 1989; SNYDER et al. 1997; BACZEK et al. 2001). By
means of these programs chromatographers can model changes in experimental conditions, optimize
methods and predict method robustness with a limited number of experimental runs, thus reducing
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the trial-and-error factor (BACZEK et al. 2001; HOANG et al. 2003). The most widely used
program for computer-assisted simulation of HPLC separation is DryLab (LC Resources, USA)
which allows the simulation of both isocratic and gradient elution (SNYDER et al. 1989; DOLAN
et al. 1989). The development of the software has recently been well described in detail by
MOLNAR (2002). The mathematical basis for the software is the linear solvent strength model
(SNYDER and DOLAN 1998; BACZEK et al. 2001).
Other programs less widely utilized for LC separation method development are ChromSword
(Merck KGaA, Germany) and Turbo Method Development (TMD) (PerkinElmer, USA). The
function of ChromSword is based on the structural formulae of solutes (BACZEK et al. 2001), and 
the function of TMD is based on data from series of experiments and selection of the best conditions
(RAUHA et al. 1997).
DryLab allows the simulation of any chromatographic separation as a function of simultaneous
changes in any one or two variables that can affect sample separation selectivity (HABER et al.
2000). This is well illustrated in studies where two of three or four variables, temperature, solvent
strength (%B), pH and buffer concentration, were separately optimized in terms of selectivity
(DOLAN et al. 1990; JUPILLE et al. 2002; HOANG et al. 2003). The most important variables that
can be changed in DryLab to simulate the separation are solvent strength (SNYDER et al. 1987),
solvent selection (QUARRY et al. 1987, SNYDER et al. 1997), gradient steepness (QUARRY et al.
1986; DOLAN et al. 1987), temperature (DOLAN 2002), pH (LEWIS et al. 1992a; LEWIS et al. 
1992b) and column conditions (SNYDER and DOLAN 1986; SNYDER et al. 1997). The examples
of isocratic method development that involve the simultaneous variation of two experimental
conditions are quaternary-solvent mobile phase with solvent strength and the run time held constant
(GLAJCH et al. 1980), ternary-solvent mobile phase with the solvent strength allowed to vary
(WEYLAND et al. 1984), binary-solvent mobile phase with the pH and ion-pairing reagent
concentration varied (KONG et al. 1980), column type and mobile phase with the percentage of
organic solvent allowed to vary (DESTEFANO et al. 1992), the mobile phase pH and percentage
organic allowed to vary (BOURGUIGNON et al. 1994), and the temperature and mobile phase
strength allowed to vary (WOLCOTT et al. 2000). A similar approach can be used for
corresponding gradient separations in which, for example, temperature and gradient time are 
allowed to vary (ZHU et al. 1996; DOLAN et al. 1998) and the gradient time and pH are allowed to
vary (BILKE et al. 1996). The ability of the program to predict isocratic separation based on data
from gradient elutions has also been studied (STUART and LISI 1991; SNYDER and DOLAN
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1996; LEWIS et al. 1996), and it has been found to be beneficial to use gradient elutions instead of
isocratic runs as the starting point for method development (SYDER and DOLAN 1996; DOLAN et
al. 1999c; MOLNAR 2002). The computer-assisted simulation program is a convenient tool when
developing the separation method for complex samples containing more than 15-20 analytes.
Separation method development for complex samples is typically difficult and requires gradient
elution, especially for samples of biological origin (DOLAN et al. 1998; DOLAN et al. 1999a;
DOLAN et al. 1999b; DOLAN et al. 1999c; SCHMIDT and MOLNAR 2002).
6.2. Bioassay-guided fractionation
The path that leads from the intact plant to its pure bioactive constituents is generally known as 
bioassay-guided fractionation. At the beginning of this path crude plant extracts are submitted to
different bioassays for rapid estimation of their bioactivity. The extracts of interest are then
fractionated with the help of various chromatographic methods. The bioassays serve as a guide
during the isolation process, and all the fractions continuing to exhibit activity are carried through
further isolation and purification until pure active principles are obtained (HOSTETTMANN et al. 
2003).
6.2.1. Bioassays
Cancer, autoimmune, heart and coronary diseases as well as microbial infections are the major
cause of death, and an important reason for poor quality of life especially in western countries.
Successful treatment of these diseases requires the discovery of new drugs. The bioassays that have
been designed for drug discovery are based on targets that are hypothetically associated with these 
diseases (DREWS 2000; VUORELA et al. 2004). 
Bioassays can be defined as tests which are used to detect the biological activity of an extract or
pure substance isolated from an extract, obtained from a living organism (HOUGHTON 2000). In
principle, the test systems can range from whole organism in vivo models to single-target cell free 
assays (HAMBURGER 2003; HOUGHTON 2000). The targets for bioassays can be classified into
five major groups: (a) lower organisms, such as micro-organisms; (b) isolated subcellular systems,
such as enzymes; (c) cultured cells of human or animal origin; (d) isolated organs of vertebrates; (e)
whole animal (HAMBURGER and HOSTETTMANN 1991). Testing at the organismic level is
closer to the biological reality, but single-target assays allow the investigation of specific
mechanism and they are easily amenable to HTS (high throughput screening). Due to time, financial
and ethical considerations, the use of isolated organs or whole tissues is limited in bioassay-guided
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fractionation (HOUGHTON 2000). Nowadays, most bioassays are designed to use very small
amounts of test material, to give results within a few days at the most, and to test many samples
within a short period of time. Microtitre well plates are widely used and the assay processes are 
automated and robotized to a very large extent (CLAESON and BOHLIN 1997; ELANDS 2001).
An advanced strategy for in vitro screening and evaluation of the efficacy of natural products is to
apply a battery of complementary in vitro assays. The assays may be composed of different cellular 
systems or a combination of cellular and non-cellular assays. Isolated cellular systems, primary cells
in culture and cell lines provide the desirable complexity of structurally and functionally intact cells 
combined with excellent experimental accessibility. Cellular screening systems allow evaluation of
the influence of natural products on cellular functions and elucidation of the mechanism of action.
This approach may lead to direct conclusions about therapeutic effects and their molecular basis and
it may also be possible to detect new interactions with cellular functions (GEBHARDT 2000).
There are however, some points that have to be considered with regard to the choice and design of a
bioassay system. The major consideration is the choice of target receptor, enzyme, cell line or other
model. The model should be relevant to the disease of interest and to its biochemical basis. The
problems related to the choice of the assays are often due to a complicated aetiology when a
portfolio of different tests should be employed to check the reputed activity of the extracts.
Problems may also occur when the aetiology of the disease is not known (HOUGHTON 2000). The
chosen model should be sufficiently sensitive to provide a quantifiable response with the amounts to 
be used. Especially in the case of crude extracts, the active principles are generally present at low
concentrations only. The selectivity of the model should be such that the number of false positives is 
reasonably small. Poor solubility of the extracts and fractions under the test conditions is relatively 
common, and therefore false negative or false positive results are a more serious problem than when
dealing with pure compounds (HAMBURGER and HOSTETTMANN 1991; HOUGHTON 2000). 
In the case of fractionation, it is not unusual that the initial extract has greater activity than the
fraction obtained (JACKSON et al. 2000). The activity of a plant extract is typically the sum of the
activities of the structurally related compounds which contribute, to a varying degree to the overall
effect (DITTMANN et al. 2004). The use of biological systems is also subject to variations in the
response of the individual organisms and cell strains. This variation necessitates the use of a large
number of replicate tests and appropriate statistical evaluation of the results. Quantification is 
needed to demonstrate the dose-response relationships and to compare the novel active substance 
with known active compounds. In addition to a positive control, a negative control should also be
included in the bioassay to ensure that the reagents and solvents used are not giving false positives
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(HAMBURGER and HOSTETTMANN 1991; HOUGHTON 2000). The use of a model system
based on a known activity also means that the mechanism of action will, to some extent, be the
same as that already known, and the novel molecular type may well be susceptible to the same
process of resistance or tolerance which occasioned the search for a novel agent (HOUGHTON
2000). Furthermore, the assays should be simple, rapid, reproducible and inexpensive
(HAMBURGER and HOSTETTMANN 1991).
6.2.2. Bioassays combined with LC separations
Modern methods developed for bioactivity screening include quite a lot of applications which
successfully interface chemistry and biology. The first screening method that successfully combined
chemo-analytical and bioassay principles was a TLC bioassay method called bioautography
(HOMANS and FUCHS 1970; HAMBURGER 2003). Bioautography is a bioactivity-related
detection method for TLC which offers the possibility of directly tracking bioactive compounds in 
complex mixtures with minute amounts of material. A micro-organism, enzyme or other
biomolecule is applied onto a developed TLC plate. After suitable incubation, zones of bioactivity
may either become directly visible or they may be visualized after a detection step involving
enzymatic conversion of chromogenic substrates (HOMANS and FUCHS 1970; HAMBURGER
2003). Bioautographic assays have been established for antifungal (FUCHS 1970), antibacterial
(HAMBURGER and CORDELL 1987) and anti-Candida (RAHALISON et al. 1991) activities. Due
to the growing interest in natural antioxidants, a bioautographic assay using stable radicals such as 
DPPH (2,2-diphenyl-1-picrylhydrazyl) as the detection reagent for radical scavengers has been
introduced (TAKAO et al. 1994). An example of a bioautographic assay for the visualization of the
interactions of natural products with isolated biomolecules is a TLC screen for acetylcholinesterase
inhibitors (RHEE et al. 2001). Another interesting variant of bioautography is an assay for
visualizing the binding properties of secondary metabolites to bio-macromolecules, e.g. DNA-
binding molecules can be detected via the differential chromatographic mobility of a compound
with and without the presence of DNA (MAIER et al. 1999). The limitations of bioautography are
mainly the restricted number of relevant biological targets, and the fact that bioautography only
provides qualitative results (HAMBURGER 2003).
The classical approach of activity-directed isolation is based on an iterative sequence of preparative
separation steps monitored by a suitable bioassay (SU et al. 2003; HAMBURGER 2003; MING et
al. 2004). Due to the advances in technology, e.g. microtitre based bioassays, HPLC-coupled
spectroscopy and miniaturization tools, it has been possible to develop HPLC-based activity
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profiling to such an extent that the process has become more effective and faster compared to 
classical methods (ZHOU and HAMBURGER 1996; CORDELL and SHIN 1999; DANZ et al.
2000; HOSTETTMANN et al. 2001; HOSTETTMANN and MARSTON 2002; QUEIROZ et al. 
2002; HAMBURGER 2003; KRAUS 2003; VUORELA et al. 2004; WARIDEL et al. 2004; IV;
QUEIROZ et al. 2005). The principle of this modern HPLC-based activity profiling process, which
is very applicable in primary screening, is shown in Fig. 1 (HAMBURGER 2003; VUORELA et al. 
2004).
Isolation
Figure 1. Principle of the HPLC-based process for detecting and isolating active compounds in
plant extracts (modified from HAMBURGER 2003 and VUORELA et al. 2004).
The most marked improvements to this new approach are the possibility to separate and fractionate
the extract by analytical gradient HPLC, to carry out the bioassays at a decreased scale, e.g. a 96-
well format, and the possibility to identify the active compounds on-line by splitting the flow and
using a portion of the effluent for on-line spectroscopic characterization of the chromatographic
fingerprint. The data from HPLC can be matched with the activity profile, and this information can 
be correlated with the simultaneously recorded spectroscopic data. The structural information can be
used for a search of natural product databases and tentative structural assignments. A targeted
preparative isolation is carried out only if the active principles are deemed to be of sufficient interest
(HAMBURGER 2003). Preparative separation methods can then be easily developed by scaling-up
the separation method used in the analytical HPLC (II; IV; VUORELA et al. 2004).
Bioassay scale fractionation, i.e. microfractionation, has been carried out in at different scales in 
practical applications of HPLC-based activity profiling. The term microfractionation has been used
in scientific articles when the fractionated sample amount has been 1 mL or less. In certain cases the
extract HPLC
Microplate
based
Bioassay
DryLab
On-line
spectroscopy
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microfractionated fractions (1 mL) have been collected in Eppendorf tubes as a function of time and
then subjected to different kinds of bioautographic assay (QUEIROZ et al. 2002; QUEIROZ et al.
2005; SIMÕES-PIRES et al. 2005). A similar approach was used when the bioactive plant extract
was first separated into relatively large 8 mL fractions, from which the active fraction was further
fractionated as a function of peak width. By measuring the bioactivity of the individual peaks in the
active fraction, it was easy to identify which peak caused the positive response in the bioassay. The
bioassay itself was carried out at the 96-well microtitre plate scale, and the analytical-scale HPLC 
separation was therefore able to provide a sufficient amount of sample for the bioassay (DANZ et
al. 2001). The microfractionated fractions have also been collected into 96-well microtitre plates
with a fraction volume of only 0.3 mL. Collection is usually carried out as a function of time
(CORDELL and SHIN 1999; DITTMANN et al. 2004; IV; V). Depending on the bioassay, the
bioactivity of the fractions in the microwell plate can be measured either in the same plate where the
fractions are already located (IV), or the fractions have to be transferred to another plate where, for
example, the cells necessary for the bioassay are growing (DITTMANN et al. 2004; V).
Combining the high separation efficiency of HPLC with different detectors such as UV (ultraviolet),
MS (mass spectrometry), NMR (nuclear magnetic resonance) and FTIR (fourier transform infrared),
has made possible the acquisition of on-line complementary spectroscopic data on the LC peak of
interest within a complex mixture (HOSTETTMANN and WOLFENDER 1997; BRINGMANN et
al. 2000; WILSON 2000; HOSTETTMANN et al. 2003; KRAUS 2003; WARIDEL et al. 2004;
JAROSZEWSKI 2005; LAMBERT et al. 2005). These hyphenated techniques are having a rapidly
growing impact on natural products research by enabling structure determination of natural products
directly from small amounts of extract. If the hyphenation to one detector does not provide the
necessary information, it is possible to build up multiple-hyphenated systems which combine, for
example, a HPLC-MS system with NMR. However, even though the hyphenated techniques provide
many possibilities, these systems include considerable challenges related to technical questions and
the price of the equipment. It should also be kept in mind that a multiple-hyphenated system is, in
practice, only as sensitive as its least sensitive detector, and that most problems do not require
particularly complicated systems to be solved.
The HPLC separation used for bioassay screening and activity profiling cannot only be combine
with microplate-based, off-line bioassays, but it can also be combined with on-line bioassays for the
direct collection of results concerning the activities of the substances under the peaks of a HPLC
chromatogram (KOLEVA et al. 2000; DAPKEVICIUS et al. 2001; SCHOBEL et al. 2001).
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Biochemical-based, on-line HPLC bioassays have been developed, for example, for the detection of
enzyme inhibitory activity (INGKANINAN et al. 2000), for the detection of estrogen receptor
binding activity (SCHOBEL et al. 2001), and for the detection of radical scavenging compounds in
complex mixtures (KOLEVA et al. 2000; KOSAR et al. 2004). Another type of on-flow assay are
flow injection systems coupled with a biosensor (HAMBURGER 2003). Biosensors are devices
combining a biological component with a suitable physical transducer. A number of mainly
enzyme-based biosensors have been designed, for a specific purpose in natural product analysis,
such as for alliin (MILKA et al. 1999) and flavonoids (CUMMINGS et al. 2001). However, there
are some limitations to these on-line systems. The most important drawback is that the conditions
used in separation need to be compatible with the conditions required for the bioassay. Also, the 
considerable consumption of immunochemicals and enzymes may represent a major cost factor
when operating such on-line assays (HAMBURGER 2003).
The development of screening procedures has resulted in a need to prioritize samples which are
deemed active. To isolate a well-known active compound is a waste of time and money. The
procedure, which determines whether a particular component should be isolated for further use, is
called dereplication (HOSTETTMANN et al. 2003). Dereplication is an integral part of the early 
stages of the drug discovey process, where the focus is on the rapid identification of novel,
biologically active metabolites from natural sources. In dereplication the physical and chemical data
are integrated with the biological activity data on well-defined subfractions of an active extract. The
HPLC-based activity profiling process, including HPLC gradient elution, microplate based
bioassays and on-line structure elucidation, provides an excellent tool for dereplication (CORLEY
and DURLEY 1994; CORDELL and SHIN 1999; LAMBERT et al. 2005).
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7. AIMS OF THE STUDY 
The overall aim of the study was to develop and study a primary screening process which would be 
linked to the targeted isolation based on a computer-assisted scale-up of the separation method. The 
primary screening would be based on analytical HPLC gradient separation and microplate scale 
bioassays. 
The specific aims of the study were: 
1) to apply the computer-assisted simulation program to the simulation of TLC separation and 
to develop an idea about how the TLC method can be transferred to the HPLC method, and 
how the HPLC method can be simulated by the computer-assisted simulation program 
based on the information from initial runs with TLC (I)
2) to demonstrate how the computer-assisted HPLC simulation program can simulate 
preparative-scale separation based either on analytical- or on preparative-scale initial runs, 
and how the isolation of bioactive compounds found in the microplate-based bioassays can 
be scaled-up from the analytical to the preparative scale by using the computer-assisted 
simulation program (II, III, IV)
3) to develop a microfractionation procedure in which the sample extract is fractionated into a 
microwell plate, and then to apply chemical- and cell-based (bacteria) bioactivity tests to 
this assay platform (IV)
4) to apply a mammalian cell based bioassay to microfractionated dwell plates, and to 
automate this particular screening method (V)
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8. EXPERIMENTAL
A detailed presentation of the materials and methods can be found in the original publications.
8.1. Materials
8.1.1. Pure compounds
The pure compounds used in the individual studies are presented in Table 1. The pure compounds
in the DPPH (2,2-diphenyl-1-picrylhydrazyl) test were used as 0.05 mg/mL solutions in methanol.
A water-soluble derivative of vitamin E trolox (Sigma-Aldrich Co., USA) with potent antioxidative
properties was used as positive control in the DPPH test at a concentration of 0.05 mg/mL (IV). The
concentrations of the pure compounds in the solution for the antimicrobial assay were apigenin 0.4
mg/mL, penicillin G 0.05 mg/mL, 3-(?-acetonylbenzyl)-4-hydroxycoumarin 0.1 mg/mL and octyl
gallate 0.2 mg/mL, dissolved in methanol. In the antimicrobial assay 20 μL of 0.1 mg/mL solution
of erythromycin (Sigma-Aldrich Co., USA) in methanol was used as a positive control (IV). In the
45Ca2+ uptake measurements, verapamil hydrochloride (40 μM) (Orion Pharmaceuticals, Finland) 
was used as a positive control with known calcium antagonistic activity. The pure compound
concentration in the 45Ca2+ uptake assay was 0.2 mg/mL for each compound (V).
Table 1. Sources of the pure compounds used in this study.
Compound Used in Source
3-(?-acetonylbenzyl)-4-hydroxycoumarin IV Sigma-Aldrich Co., USA
Apigenin IV Sigma-Aldrich Co., USA
(+)-Catechin I, III Sigma-Aldrich Co., USA
Gallic acid I, IV, III, II Sigma-Aldrich Co., USA
Imperatorin V Extrasynthése, S.A., France
Isorhamnetin I, IV Extrasynthése, S.A., France
Naringin I, IV, III Carl Roth Gmbh & Co, Germany
Naringenin II Carl Roth Gmbh & Co, Germany
Octyl gallate IV Fluka Chemie, Switzerland
V Extrasynthése, S.A., France
Penicillin G IV Fluka Chemie, Switzerland
Quercetin I, IV, III, II Extrasynthése, S.A., France
Rutin I, IV, V, III Merck & Co. Germany
Verapamil V Orion Pharmaceuticals, Finland
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8.1.2. Plant material
Allium cepa L. (onion) was used to demonstrate the possibility of using DryLab in scaling-up the
separation method for a plant extract (II). The A. cepa was obtained from a grocery store
(Stockmann Oy, Finland) in September 2000. The edible part of A. cepa was chopped and extracted
with methanol (HPLC grade, Rathburn, Walkerburn, Scotland) (35g A. cepa/20mL MeOH) using a 
mixer (IKA labortechnik, T25B, Staufen, Germany) and sonicator (Elma, transsonic 460, Germany).
The extract was centrifuged and the supernatant was used as the sample.
Extracts of Lythrum salicaria L. (purple loosestrife), Linum usitatissimum L. (linseed) and Cladina
stellaris (Opiz) Brodo (star reindeer lichen) were used to demonstrate the applicability of the
microfractionation procedure, combined with bioassays, to natural product samples (IV). Herb of L.
salicaria was collected during the flowering season in Helsinki, Finland, during July 1998. The
seeds of L. usitatissimum were obtained in August 2000 from Ravintorengas Oy (Finland). C.
stellaris was collected during March 1984 in Sipoo, Finland. L. salicaria and L. usitatissimum were
dried and powdered. 1 g of ground plant material was weighed into a test tube. 10 mL of 80% (v/v)
aqueous methanol was added and the suspension was stirred. The tube was sonicated for 10 min and 
centrifuged for 10 min (2800 rpm). The supernatant was pipetted into a 250 mL round-bottomed
flask. Each plant sample was extracted three times. The combined supernatants were evaporated
(water bath 35?C) to a volume of about 2 mL and lyophilized to dryness. The dry residue was
extracted with methanol (5 x 4 mL) into test tubes. The tubes were centrifuged and the supernatant
was evaporated under a nitrogen stream to a final volume of 2 mL, which was lyophilized to
dryness. The dry extract was dissolved in the methanol as a concentration of 20 mg/mL. Dried and
powdered C. stellaris was extracted by weighing 80 mg of sample material into a test tube and
adding 1 mL of methanol on top of the sample. Sonication and centrifugation were carried out as
described above. The supernatants from three extractions were filtered with a syringe-driven 0.22
?m filter (Sterile Millex, Millipore, USA). The filtrate (2.5 mg/mL) was used as the sample for 
fractionation.
Extracts of Peucedanum palustre L. Moench (milk parsley) and Pinus sylvestris L. (Scots pine)
were used to demonstrate the applicability of the combination of microfractionation and 45Ca2+
uptake assay in detecting calcium antagonistic components of natural products (V). Roots of P.
palustre were collected in Kirkkonummi, Finland, during June and July 2000. Air-dried and
powdered P. palustre root material (1 g) was extracted with 3 × 10 mL of methanol-water (80:20,
v/v) (sonication 10 min, centrifugation 1500 × g, 10min). The combined supernatants were
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evaporated (water bath 35?C) to a volume of about 2 mL and lyophilised to dryness. The dried
extract was dissolved in a mixture of methanol and DMSO (1:1, v/v) to yield a final concentration
of 20 mg/mL. Ground cortex of P. sylvestris was obtained in August 2000 from Ravintorengas Oy
(Finland). The ground cortex was produced according to the company’s quality requirements. The
material was extracted with acetone-water (70:30, v/v) for 48 hours. The extract was lyophilised and
the raw extract was further purified using liquid-liquid extraction with n-hexane, chloroform and n-
butanol, respectively. The sample was finally collected and lyophilised for use in this study.
All the plants were identified by Pia Fyhrqvist (M.Sc. (Bot.)), except for P. palustre which was
identified by Docent K. Fagerstedt of the Division of Plant Physiology, University of Helsinki,
Finland. Voucher specimens of all the plant samples are deposited at the Faculty of Pharmacy,
University of Helsinki, Finland.
8.1.3. Instrumentation
The HPLC (high performance liquid chromatography) system consisted of a PerkinElmer Series
200 LC pump and Autosampler (PerkinElmer Inc., USA) with 200 ?L loop, PerkinElmer LC 235 C
Diode Array Detector at a scanning wavelength of 195–365 nm (PerkinElmer Inc., USA) and PE 
nelson 600 series link (PerkinElmer Inc., USA) (I, II, III, IV, V).
8.1.4. Columns and TLC plates
The columns and TLC (thin layer chromatography) plates used for the respective studies were:
TLC glass plates 20 x 20 cm TLC RP-18 F254 s, Artikel no 1.15389. (Merck KGaA,, Germany) (I).
LiChroCART 250-4, Hypersil ODS, 25 cm × 4 mm i.d., 5 μm (Merck KGaA,, Germany) (II).
Büchi 17982, 460 mm × 26 mm i.d. (Büchi Laboratoriums-Technik AG, Flawil, Switzerland)
packed with 145 g of Lichroprep RP-18, 15-25 μm, Art. 13901 (Merck KGaA,, Germany) (II, IV).
SupelcosilTM LC-18, 25 cm × 4.6 mm i.d., 5 μm (Supelco, USA) (I, III, IV).
Discovery HS C18, 25 cm × 4.6 mm i.d., 5 μm (Supelco, USA) (V).
SupelcosilTM LC-18, 25 cm × 21.2 mm i.d., 12 μm (Supelco, USA) (III).
8.1.5. Computer programs
The program used for HPLC, preparative HPLC and MPLC method development, method
optimization and method scale-up was DryLab 2000 plus (LC Resources, USA) (I, II, III, IV). The
program used for statistical analyses was Systat 10.2 (SYSTAT Software Inc., USA) (III, IV).
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8.2. Methods
8.2.1. DryLab simulation (I, II, III, IV)
For DryLab the properties of the LC system were tested. Flow rate, proportion accuracy and
gradient linearity were confirmed as acceptable. For the simulations dwell, i.e. void, and the dead
volumes of different system assemblages were determined.
All the column liquid chromatographic simulations were based on two initial linear gradient runs in
which the variable was the gradient time. Peak tracking was performed on the basis of the
information from initial runs, and the retention times, peak areas and, if necessary, asymmetry
factors from the peaks that were found to be equal were fed into DryLab. When all the parameters
including column and mobile phase information were fed and accepted in DryLab, the separation
conditions were simulated.
In the TLC simulations the dead time was considered to be absent and the development distance
was used as the column length. The particle size was estimated to be 5 ?m. The flow rate in TLC
cannot be adjusted in the simulations and it was therefore kept constant (1 mL/min). The TLC
simulations were based on initial TLC separations, and the simulation modes were either “LC-RP
Isocratic %B 2 runs” or “LC-RP Isocratic %B 3 runs”. The retention times from initial runs for each 
substance were fed into data entry. The retention times that are required by DryLab data entry were
obtained from TLC by using the inverse of the Rf values (retardation factor) (1/Rf). After the
simulation, the simulated retention times were transformed back to Rf values and compared to
experimental retardation values.
To improve the ability of DryLab to simulate the peak widths, the simulated peak widths were 
calculated from the equation W2 = W02 + Wth2 (SNYDER et al. 1988) (III), where the final 
bandwidth W is the sum of small sample contribution to bandwidth W0 and the mass over-loaded
contribution to bandwidth Wth. In this study W0 was measured from the analytical initial runs at 10
% peak height. Wth was calculated from the equation: 2.3(t0/b)(w/ws)z  (COX et al. 1988), where t0 is
dead time, b is a gradient-steepness parameter, w is amount of the compound at issue in the sample
(mg), ws is column capacity for preparative column (0.4 * column surface area, m2) (SNYDER et al.
1997) and z is slope of the plot of Wth vs. w. Gradient-steepness parameter b was calculated from
the equation b=Vm ?? S/tGF, where Vm is column dead volume, ?? is the change in the volume
fraction, ?, of the organic solvent during the gradient (?%B/100) and S is an isocratic property of
the solute (COX et al. 1989). A good estimation for S is S=0.48M0.44, where M is the molecular
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weight of the solute. Furthermore S can be estimated as 5 when it is the case of small molecules.
The best value for z was found to be 0.45 which is in good agreement with the results reported by
COX et al. (1989).
8.2.2. LC separations (I, II, III, IV, V)
All the eluents used in the LC separations consisted of 0.1 % (v/v) aqueous formic acid (Riedel-de
Haën, Seelze, Germany), in which the water was purified via a Millipore MilliQ filtration system
and either methanol (HPLC grade, Rathburn, Walkerburn, Scotland) (III, IV, V) or acetonitrile
(HPLC grade, Rathburn, Walkerburn, Scotland) (I, II). The temperature was monitored during the
studies and the experiments were carried out under isothermal conditions.
The HPLC (high performance liquid chromatography) and MPLC (medium pressure lliquid
chromatography) separations were either initial gradient elutions for DryLab simulations, or the 
separation methods were developed by DryLab. For fractionation purposes a linear full-scale
gradient (5-95 B%) was carried out when the sample solutions were separated for the 45Ca2+ uptake
assay (V). More detailed information about the LC separation conditions are presented in articles.
For the TLC (thin layer chromatography) experiments the glass plates were cut to smaller (4 x 10
cm) sizes. The elution distance was 81 mm and the plates were developed in non-saturated normal
flat bottom chambers. The acetonitrile concentrations (%B) were 25, 30, 35, 40 and 45% (v/v). One
sample per plate was applied to the plates as a 5 mm band using a Linomat IV application device
(Camag, Muttenz, Switzerland). The application speed was 15 s/μL and the sample amount was 5
μL. The results from the plates were scanned at 255 nm in reflectance mode using densitometer CD
60 (Desaga, Weisloch, Germany).
8.2.3. Microfractionation (IV, V)
The HPLC separations were performed by gradient elution at the flow rate of 1 mL/min. The
separated samples were all fractionated on an automated fraction collector (Gilson FC 204, Gilson
Inc., USA). The fractions were collected in 96-well microplates with a volume of 330 ?L/well
(Nunc A/S, Denmark). Fractionation was performed as a function of time, with a collection time of 
0.3 minutes per well. To match the peaks in the chromatogram with the fractionated microplate
wells, the dwell time from the detector to the fraction collector and the lag time caused by the
injection were determined. As a result, there was a 0.1 min difference in our system between the
collection time and appearance of the peak in a chromatogram. At least six wells were left empty in
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the plates for positive and negative controls. Fractionated plates containing the control solutions
were frozen and then lyophilized (HETO LyoPro 3000, Heto-Holten A/S, Denmark) for 12 hours
before being subjected to the tests.
8.2.4. Microplate assay for radical scavenging activity (IV)
The radical scavenging assay applied on microplates was modified from the commonly used DPPH
test (BRAND-WILLIAMS et al. 1995). The sample solutions were fractionated in 96-well
microplates as described in the microfractionation chapter. To develop the method, six test
compounds were fractionated into twelve wells. In order to evaluate the DPPH test applied on a
microplate as a primary screening tool, methanol extracts of L. salicaria and L. usitatissimum were
fractionated. A positive control trolox (0.05 mg/mL, 20 ?L) was added manually in three empty
wells on each fractionated plate. Three empty wells per plate were used as negative controls.
Lyophilized microplate wells containing either fractions or controls were filled with 200 ?L of 15
?M DPPH solution. After addition of DPPH solution, the plates were shaken for one minute and
protected from light up until measurement at ambient temperature. The decrease in absorbance of 
the wells at 520 nm was determined automatically by a Wallac Victor2 V multilabel counter (Perkin
Elmer Life and Analytical Sciences/Wallac Oy, Finland) after 30 min. The activity was calculated
as the percentage of absorbance inhibition, 100?(ADPPH-Afrac)/ADPPH, where ADPPH was the average
absorbance of the wells filled with the DPPH solution, and Afrac was the absorbance of a well that 
contained both the fractionated sample and DPPH solution.
8.2.5. Microplate assay for antimicrobial activity (IV)
The sample solutions for the antimicrobial test were separated by HPLC, and the fractions were
collected in 96-well microplates as described in the microfractionation chapter. The lyophilized
microplates were tested against Streptococcus pyogenes ATCC 12351. The cultures had been kept
at -70oC prior to use. Before the strains were used in the test they were grown in Todd-Hewitt broth
(Oxoid, CM189, In vitro Diagnosticum, Basingstoke, Hampshire, England) at 37oC in 5% CO2 for
24 h. 260 ?L of the bacterial suspension (108-109 CFU/mL) was added to the microplate wells, 
which were either empty or contained lyophilized fractions or erythromycin as a positive control.
Prior to addition of the bacterial suspension, 1 ?L of dimethyl sulfoxide, DMSO (Merck Eurolab,
Darmstadt, Germany) was pipetted into the wells. The microplates were incubated with continuous
shaking at 37?C for 6 hours. The turbidity of the wells containing fractions and suspension (Af), the
wells containing only the bacteria suspension (Ab), and the wells containing bacterial suspension
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and the positive control (Ae), were measured at one-hour intervals on a Wallac VICTOR2 V 
multilabel counter at 620 nm. The turbidity of the wells was determined as a measure of microbial
growth (SKYTTÄ and MATTILA-SANDHOLM 1991). The percentage growth inhibition (PI%)
was calculated using the equation: PI% = 1-(Af-Ae) / (Ab-Ae). Erythromycin inhibited totally the
growth of Str. pyogenes, and therefore Ae corresponds to the turbidity caused by the initial cell
amount, the well itself and the Todd-Hewitt solution used in preparing the bacterial suspension.
8.2.6. Miniaturised 45Ca2+ uptake assay (V)
Depolarisation-induced 45Ca2+ uptake assay in clonal rat pituitary cell line GH4C1 was carried out in
a 96-well plate format. Cell seeding density (range 2 × 104 to 1 × 105 cells/well) and culture time
(from 1 to 7 days) were optimised by following cell proliferation on the basis of protein
determination according to BRADFORD (1976). After optimisation, the cells were seeded at a 
density of 8 × 104 cells/well, cultured in the plates for 3 days before the experiments, refed once,
and assayed following the procedure of TÖRNQUIST and TASHJIAN (1989). Cell-associated
radioactivity was measured using a liquid scintillation counter (Microbeta® Trilux, Perkin-Elmer
Life and Analytical Sciences/Wallac Oy, Finland). The suitability of the assay for automation was 
evaluated by conducting a series of experiments on a Biomek FX workstation (Beckman Coulter,
Inc., USA). The miniaturised 45Ca2+ uptake assay was coupled to HPLC microfractionation of
sample solutions (a reference solution and crude plant extracts). The microfractionations were
carried out as described in chapter 8.2.3. Fractionated samples were lyophilised for 24 hours,
dissolved in assay buffer, and the calcium antagonistic activity of the fractions was measured with
the 45Ca2+ uptake assay. 
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9. RESULTS AND DISCUSSION
9.1. Computer-assisted simulation of TLC separation (I) 
DryLab was successfully used to simulate reversed phase TLC (thin layer chromatography)
separations of phenolic compounds on the basis of the information from initial TLC separations
(Table 1 in I). It was found beneficial to use the 1/Rf values directly as retention times in DryLab
instead of converting the Rf values (retardation factor) at first to k’p values and then to retention
times. The most accurate result was achieved when the simulation was based on three initial runs 
and the simulated conditions were at the same B% range as the initial runs (Table 1, sim 11 in I). In
simulation 11, the simulated Rf values were practically the same as the experimental Rf values. The
simulations based on two initial runs were also very consistent with the experimental retardation
values. The simulated retardation in TLC was found to be adequate enough in most cases when the
simulated conditions were inside the B% range used in the initial runs. Another important factor 
was the difference in B% between initial runs. All the results suggested that the difference in
organic modifier concentrations between two adjacent initial runs should be more than 5%.
The simulation accuracy depended on the quality of the initial runs. Difficulties in matching the
simulated separations with the experimental separations may appear when the peaks begin to
converge. For example, due to the high B% peak retardation and resolution decreases in
experimental separations and the detection of the peaks becomes more difficult, thus the comparison
of simulated and experimental peaks becomes more difficult.
In order to achieve a reliable TLC simulation it is recommended to run three initial TLC separations
in which the difference in B% between adjacent runs is more than 5%. It is also advisable to use a
Rf range of 0.15–0.7 (GEISS 1987). The information needed for reliable simulation, which should
be gained from the initial runs, may not be obtained if the sample is too complex or if the polarity of
the compounds of interest is either too similar or too different. The required initial data cannot be
obtained if the spots are not separated or if all the compounds do not move from the initial spot.
The particle size data in DryLab does not have an affect on the retention times. However, the use of 
relatively small particle sizes in data entry helps to visualize the peaks in the simulations. The
simulated chromatogram produced by DryLab was found to mimic the TLC densitogram when a 
small particle size was used in the simulation settings; however, the peaks are in reversed order (see
Fig. 1 in I).
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The possibility of transferring the separation method from reversed phase TLC to reversed phase
HPLC by comparing the k’ values (k’p and k’c) as a function of B% was also tested (Fig. 2 in I).
The results in Fig. 2 in I illustrate that there is a clear difference in the slopes of linear functions
between k’p and k’c, which means that changes in B% affect more drastically HPLC than TLC.
Thus, in order to be able to convert the separation method from TLC to HPLC, and to ensure that
neither the retention times nor the selectivity would change markedly, this feature needs to be taken
into account. In order to study the transferability of TLC to HPLC further a comparison of the k’p
and k’c values, as reported by REUKE and HAUCK (1995), was carried out (Fig. 3 in I). The k’c
values for isocratic HPLC separations were calculated from the DryLab simulations, and the k’p 
values were calculated from the experimental TLC separations according to the equation k’p = 
(1/Rf)-1 (GEISS 1987). The regression between k’p and k’c for each compound was studied and the
results are presented in Fig. 3 in I. Interestingly, in contrast to the results of REUKE and HAUCK
(1995), in our experiments a power function gave a better correlation value in most cases than the
linear equation. In our study it was not possible to obtain 1:1 transferability for compounds from
TLC to HPLC. However, when the k’p values from the experimental TLC separations were
converted to k’c values using the regression functions giving the best correlation factors, the
converted k’c values were very similar to the simulated k’c values (Table 2 in I). This finding
suggests that, if the regression function between k’p and k’c is known for each compound, then the
TLC separation can be transferred to HPLC. Thus it is possible to optimize HPLC separation using
the information from TLC separations and the simulation program DryLab. The simulations should
be carried out in “LC-RP isocratic %B (3 runs)” –mode, all the necessary retention data being
obtained from the TLC separations. This information is then applied to the same column conditions
as those used in the k’c value measurements.
9.2. Computer-assisted simulation and scaling-up of the column liquid chromatographic
separation method (II, III, IV)
The ability to use the computer-assisted simulation programme DryLab for scaling-up a separation
was tested by simulating a preparative MPLC (medium pressure liquid chromatography) separation
of phenolic compounds based on the information from initial analytical runs (II). In MPLC
simulation (Fig. 3 in II), the changes in column and equipment conditions were taken into account
as described in Table II in II. The real preparative separation of the test mixture is shown in Fig. 4
in II. The peak size ratios of quercetin and isorhamnetin changed between the simulation and real
separation, due to the different concentration ratios of the sample in the analytical and preparative
separations. The match of the peak retention times between the simulation and real life separation is 
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illustrated in Fig. 7 in II. Even though the curves do not match exactly, the retention time curves run
almost in parallel.
The developed scaling-up procedure was also applied to the plant extracts. Simulated separation of
the onion extract is shown in Fig. 6 in II, and the real separation in Fig. 7 in II. The retention times
of the simulated and real separation of onion are compared in Fig. 8 in II. This comparison shows
that the simulation and the real separation are practically the same for the peaks of interest A-E. The
peaks eluting before peak A could not be simulated because they eluted in the dwell volume during 
the initial runs. The simulated peaks after peak E are spread so that the peaks cannot be detected
properly, and they cannot be considered to have been simulated due to the problems in peak
tracking.
The first two up-scaled MPLC separations were made under linear chromatographic conditions,
which can be done when working at a laboratory scale. However, the column may sometimes be 
slightly overloaded especially when separating the plant extracts. To show that DryLab can still be
used as an up-scaling tool when working with slightly overloaded columns, a new phenolic
compound test mixture was made with higher concentrations and the sample volume of 8 mL. The 
result is presented in Fig. 9 in II, where it can be seen that the slight sample overload does not seem 
to have a marked effect on the retention times. The shape and the width of the peaks are not the
same as in linear chromatography.
The scaling-up procedure was also applied to the separation of the bioactive components of Cladina
stellaris (IV). The optimum MPLC separation for the active compounds of C. stellaris that was 
developed on the basis of the data from the analytical gradient elutions was found to be isocratic
elution at B% 95 in 160 min (Fig. 6 in IV). Also in this study, the DryLab assisted scaling-up
procedure was found to enhance considerably the isolation of active compounds. The scaling-up
process requires the same preliminary experiments as would be needed if the analytical scale elution 
would be optimized and the information from the full-scale gradient separations in the fractionations
can be used for scaling-up purposes (IV).
The applicability of DryLab in predicting the chromatographic behavior of phenolic compounds in 
the laboratory-scale preparative separation was studied. The retention times were found to be
statistically equal at different concentrations (25, 15, 10 and 5 mg/mL) (III). The precision of the
simulated retention times in preparative separation was found to be better when the simulation was
based on initial runs made with a preparative column instead of an analytical column. However, the
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separated samples in preparative-scale elutions are always fractionated, and therefore it is more
useful to know the start and the end points of the peaks instead of the retention times. When the
sample load in actual separation is approximately the same as the sample load used in initial runs for
DryLab optimization, then the peak widths are well simulated. Four actual separations with sample
loads of 20, 40, 60 and 100 mg were compared to the simulated peak widths that were based on
sample load of 25 mg used in preparative-scale initial runs. Only the smallest sample load (20 mg)
in the actual separation correlated with the simulation. The correlation values were 0.99 for
naringenin and 0.97 for quercetin. When the sample load in the actual separations was increased up
to 40, 60 or 100 mg, DryLab was not able to take the increased sample loads into account in the
simulations. To improve the ability of DryLab to simulate the peak widths at a preparative scale, the
equation W2=W02+Wth2 was used to re-estimate the widths of the simulated preparative peaks for 
naringenin and quercetin. The calculated peak widths are presented in Table I in III. The
summarized band width for naringenin and quercetin peaks was predicted to be 6.7 min wide at 10
% peak height. Fig. 3 in III shows that the real peak combination of naringenin and quercetin is 6.5 
min wide. In a good simulation the locations of the simulated and actual peaks correspond. The
DryLab simulation based on analytical-scale initial runs gave the end of the preparative peak which
can be used to locate the peaks (Fig. 3 in III).
A good simulation of preparative separation is based on the assumption that all the compounds of
interest can be separated at the HPLC scale. To achieve such a successful simulation, peak tracking
needs to be performed carefully for DryLab. Sometimes even three or more initial HPLC run are 
needed to be able to identify all the necessary peaks, especially when working with plant-derived
material, in order to overcome the problems related to peak overlapping. Nevertheless, if peak
tracking is performed properly and the compounds of interest are separated, then the gradient
profiles suggested by DryLab work well in a preparative column. If the initial runs produce any
tailing or fronting peaks, then the asymmetry factors should be put into the data entry. In simulation
it is appropriate to use a relatively low column plate number and to have gradual gradient formation.
The more similar are the stationary phases between analytical and preparative columns, the more
accurate the simulations that can be achieved.
The computer-assisted simulation program was a convenient tool for scaling-up a separation method
from analytical to preparative scale. At optimum conditions only three runs are required, two initial
runs in HPLC and an actual preparative separation. If a good preparative separation can be
simulated in DryLab then a good preparative separation will be achieved in practise. The separation
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is predicted in most cases with sufficient accuracy. However, it may sometimes be necessary to 
carry out at least one test separation at the preparative scale in order to check the retention times.
Computer-assisted scaling-up of a separation method requires considerably less experimental
separations than the traditional trial-and-error scale-up procedure. Thus the time and effort spent on
the preparative separation method development can now be decreased remarkably. In addition the
simulation program enables the researcher to study the chromatographic behaviour of the sample
under enormous amount of different kind of conditions without any additional experimental
separation.
9.3. Microfractionation (IV)
In order to demonstrate that the bioactivity in the wells is linked to the peaks in the chromatogram,
the accuracy of the fractionation was studied. The fractions of the test solution for the antimicrobial
assay using pure compounds were analyzed by HPLC (see Fig. 1 in IV). The chromatograms
demonstrate that fractions VII, VIII, XI and XII were fractionated accurately, and that they 
contained only one peak. Fraction IX contained not only the coumarin peak, but also a trace of the
apigenin peak. Fraction X showed two peaks, which originated from apigenin, coumarin and
impurities. Fraction IX illustrates the possibility of overlapping between two adjacent peaks. In this
case the concentration of the trace peak caused by apigenin was very low compared to the main
peak, and it did not show any activity. Penicillin G peak was separated into fractions I-IV. The
degradation of penicillin appears as two peaks in fractions I-IV, whereas there is only one peak in
the chromatogram of the total sample.
The repeatability of fractionation was studied for the DPPH (2,2-diphenyl-1-picrylhydrazyl) test
with the test solution consisting of pure compounds (Fig. 2 in IV). There were 36 DPPH activity
measurements for twelve fractions. The mean and standard deviation were calculated for all the
fractions. Fig. 2 in IV shows that all the measurements were between the limits of ? 3 x standard
deviation, except for five individual data points which fell outside the limits. The within day
repeatability was studied by comparing the relative standard deviation (RSD) of the absorbance
units of individual fractions from each plate. The outliers mentioned above were omitted and the
RSD for the fractions varied by 1%–25% and the average RSD value was 10%.
In microfractionation, the fractions can be collected either as a function of time or as a function of
the peak signal. In primary screening it is often appropriate to collect peaks as a function of time
rather than as a function of the peak signal. In the case of complex samples the size of the peaks of 
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interest varies considerably, and it is difficult to adjust the settings so that the collector can
recognize both the largest and the smallest peaks. There may also be a number of compounds that
cannot be detected as peaks at the wavelength used. Collection as a function of the peak signal is
suitable only when certain interesting peaks are to be collected.
Collecting the maximum volume of sample per well increases the possibility of detecting the
bioactivity. The highest possible sample concentration can be achieved by fractionating one peak
per well. For this purpose the peaks should be as narrow as possible due to the low well volume in
the microplate. The sample concentration can be increased by increasing the injection volume.
However, increasing the injection volume broadens the peaks. An injection volume of 20 ?L was
found to produce a sufficient amount of sample for the bioactivity tests used in this study. The peaks
are often broader than can be collected in one well, or they do not exactly coincide with a well. This
may decrease the activity in the well compared to the actual activity of the peak. False negative
results can be avoided by using the highest possible concentration of the whole sample in the
fractionation.
In addition to the need for small sample amounts, one considerable benefit of the procedure
presented here is the separation of interfering colored components from other compounds. For
example, ELOFF (1998) was not able to determine the turbidity of microcultures with a microplate
reader because of the presence of colored compounds in non-separated samples. This problem can
be overcome by using the microfractionation procedure. Furthermore, the fractions are not affected
by the matrix and therefore there is a higher probability of hitting an active substance in a fraction
than in the whole extract, even though the concentrations are low. On the other hand, the synergistic
bioactivity caused by several different components may not be seen when the sample is fractionated.
In bioassays, as a consequence of the relatively low limit of detection, a non-visible amount of the
active compound may be located under a non-active but much larger peak. False identification of 
active compounds can be difficult to detect. Special attention needs to be paid to the overlapping of
active compounds that cannot be detected by a UV detector. False positive results can be avoided by
using the whole UV range in detection and/or simultaneous MS detection. The lyophilizator may
cause false negative results in the microfractionation process. If the active substances are volatile
they are most likely lost during lyophilization.
Much of the work spent on LC separations and bioactivity assays can be avoided by using the
microfractionated samples in bioassays during a primary screening process. HPLC-fractionated
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samples can be used to identify some already known compounds in samples on the basis, for
example, of UV or MS spectra, thus avoiding the unnecessary isolation of common constituents.
The MS can be connected directly to the microfractionation system by adding a splitter before the
fraction collector. It is then possible to obtain a HPLC chromatogram, UV spectrum, MS spectrum 
and fractionated microplate for bioactivity test from one HPLC separation (HAMBURGER 2003).
When the bioassay scale is transferred from traditional test tubes to well plates several advantages
can be achieved. Bioassays using the well plate format are more easily automated (including
processing and signal detection), the amount of test compounds can be reduced, significant savings
are due to the decreased need of solvents, reagents and the sample volume is considerably lower in
well plate assays compared to milliliter volumes needed to be handled with the test tubes. Currently,
a 96-well assay, which has become a standard bioassay format in pharmaceutical industry, is usually
performed in 100-200 μL volumes. Miniaturization of assays to 384-well plates or to 1536- well
plates decreases the sample volume to 50 and 5 μL, respectively (Oldenburg et al. 2002). A typical 
96-well plate assay consume on the order of 1.0–0.5 μg of test compound per test which was also
demonstrated in this study. This amount of totally unknown compound is usually also adequate to
structure elucidation carried out using NMR and MS. 
9.4. Microfractionation combined with a microplate assay for radical scavenging activity
(IV)
The radical scavenging assay was successfully applied to the microplate technique and, when
combined with microfractionation, it seemed to be a useful chemical assay for primary screening.
The activities of the microfractionated pure compounds in the DPPH test are presented in Fig. 3 in 
IV. The peaks of both gallic acid and isorhamnetin required three wells to be fractionated. Quercetin
required two wells, and trolox formed two peaks, the main peak and the minor impurity peak, that
were both collected in their own wells. The results of Lythrum salicaria fractions are shown in Fig.
4 A in IV. It is evident that L. salicaria is a good candidate in the search for antioxidative
compounds. Most of the active fractions show an almost complete loss of absorbance equal to the
absorbance of the control trolox. Linum usitatissimum did not show any activity.
In the bioactivity assays it is important to discriminate between the responses from active and
inactive fractions. A common procedure is to set a signal window based on the standard deviation
value of the negative control signal in the screening assay or to use a threshold value
(SITTAMPALAM et al. 1997). The DPPH test was so repeatable that the S.D. value was very close
to zero. As a result, almost the whole sample of L. salicaria (Fig. 4 A in IV) would have shown
42
activity if the limit had been set to 3 x S.D., which is the theoretical minimum hit limit dictated by
the variability of the measured signal (SITTAMPALAM et al. 1997). In the case of the chemical
assay, however, it was found to be more appropriate to use a threshold value instead of S.D. A 
threshold value such as 50% of the maximum absorbance reduced the number of active fractions
found in the L. salicaria extract to a much more reasonable level than when using a signal window
based on the S.D. value.
9.5. Microfractionation combined with a microplate assay for antimicrobial activity (IV)
To combine the microfrationation with a cell-based assay the antimicrobial activity of a reference
solution was used to assess the system and two plant extracts were studied by adding the microbial
cells to fractionated and lyophilized samples in the microplate wells. For the fractionated test 
solution, one highly active antibiotic, two slightly active phenolic compounds, and one inactive
coumarin were selected. The results of the antimicrobial activity of fractionated pure compounds are 
presented in Fig. 5 in IV. The figure illustrates the high activity of penicillin. Even though the wide
penicillin peak had to be fractionated into six wells, and the fractions were therefore highly diluted,
the first five fractions caused full inhibition. If the penicillin had been fractionated into one well the
theoretical maximum concentration in the well would have been 3.3 ?g/mL after addition of the
bacterial suspension. Thus, a concentration of less than 0.5 ?g/mL is sufficient to show the activity
in this assay. 
The antimicrobial activity of fractionated L. usitatissimum and Cladina stellaris with an observation
time of four hours are presented in Fig. 4 B and C in IV. Six active wells were found for C.
stellaris. The mean value was calculated for bacterial growth, and the hit limit was set to -3 x S.D. 
(SITTAMPALAM et al. 1997), which corresponds to 0.285 absorbance units. In the antimicrobial
test it was possible to identify precisely two active peaks and no further fractionations or separation
optimizations were subsequently required.
In the antimicrobial activity assays the observation period for the results varied from three to six
hours. During the first two hours the cell density was not high enough to indicate reliable
differences in growth between the control and the wells containing samples. On the other hand, the
observations were continued until bacterial growth had reached its maximum after 6 hours. The best
observation times for the results were achieved after three to four hours. The antimicrobial activity
has been shown to be dependent on the sample concentration and the incubation time
(VOGELMAN et al. 1986). The decrease in activity as a function of time shown by octyl gallate
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corresponds with the results of KUBO et al. (2002), in that the amount of sample molecules needs to
be increased with increasing number of viable cells.
A critical issue in cell-based assays is the solubility of the fractions at the bottom of the wells. Cell
suspensions are based on aqueous solutions, and it is not possible to use large amounts of organic
solvents to dissolve the sample. An aqueous solution is such a strongly polar solvent that the
solubility of the non-polar fractions must always be suspected. The amount of DMSO (1 ?L) used 
to enhance the solubility showed no effect on the growth of the used bacterial strain used. 
9.6. Microfractionation combined with a miniaturised 45Ca2+ uptake assay (V)
The automated, miniaturised 45Ca2+ uptake assay in GH4C1 cells was successfully coupled to HPLC 
microfractionation of the plant extracts. The accuracy of the integrated assay in detecting calcium 
channel antagonists and the effects of microfractionation and lyophilisation were assessed with a
reference solution containing verapamil, octyl gallate, imperatorin and rutin. The theoretical final
concentration of the compounds was calculated to be 16 μg/mL in the 45Ca2+ uptake assay. These 
concentrations yielded inhibitions of 100, 93, and 79 for verapamil, imperatorin, octyl gallate,
respectively, when the effects of these compounds on the 45Ca2+ uptake were measured without a
prior HPLC microfractionation step. No effect was observed with rutin. For the microfractionated
reference solution, the following inhibitory effects were detected: verapamil 34-79% (fractionated
into 5 wells), imperatorin 6-42% (fractionated into 3 wells), octyl gallate 11-49% (fractionated into
2 wells), and rutin showed no effect (Fig. 1 in V). These results clearly indicate that the HPLC
microfractionation did not cause any significant loss of activity in the model compounds, although
direct comparison of the results between unfractionated and fractionated samples was not possible
due to the fractionation of one compound into several wells. Based on the experiments made with
the reference solution, the threshold for considering a substance active was set at 30%.
Primary detection of calcium antagonistic components from plant extracts was performed in order to
further demonstrate the suitability of the assay for diverse types of complex samples. A root extract
of Peucedanum palustre causing a total inhibition of 45Ca2+ flux, and a Pinus sylvestris extract 
showing no activity, were chosen as model extracts for the experiments. HPLC microfractionation
of the extracts was performed, the fractions were lyophilised, dissolved in assay buffer and 
subjected to the 45Ca2+ uptake assay. The HPLC chromatograms were combined with activity
profiles, thus enabling us to detect the active components directly from the chromatogram (Fig. 2 in
V). The calcium channel blocking activity of the P. palustre root extract could be linked to
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components identified by HPLC-UV, LC-MS and the retention times as isoimperatorin and
columbianadin. Columbianadin has previously been reported to be the most active calcium channel 
inhibiting compound in the root extract of P. palustre (VUORELA 1988). As anticipated, no 
significantly inhibitory components were detected in the P. sylvestris extract (inhibitions under 
18%) (Fig. 3 in V).
The screening process combining microfractionation and 45Ca2+ uptake assay has several benefits.
First of all, the volume of the sample used for one fractionation was only 20–40 μL. Secondly, the
sample preparation needed after the microfractionation before performing the Ca2+ uptake assay is 
simple and fast because the samples for the assay can be prepared directly in the plates used for 
microfractionation after lyophilisation. The procedure clearly facilitates the detection of calcium
antagonistic components in crude extracts by excluding the need for preparative chromatographic
separation. One limiting factor is the small volume of the wells in 96-well plates, which means that
one peak occasionally has to be fractionated into several wells, thus sometimes preventing the
detection of active components with low concentrations. This can be overcome, however, by using
deep-well plates that enable the collection of larger fractions and higher concentration of samples.
10. CONCLUSIONS
The primary screening process from initial separation to the preparative-scale isolation of bioactive
compounds has traditionally been a long and tedious process requiring substantial manpower and 
financial sources. However, by developing the process techniques the time and resources can be
used more efficiently. 
The computer-assisted simulation program DryLab has proved to be a useful simulation program
not only in the analytical- but also in the preparative-scale reversed phase separations. The
experiments demonstrated the power of DryLab in the optimization process of preparative reversed
phase separation at the laboratory-scale on the basis of the analytical-scale separation. This feature 
enables the use of initial HPLC separations in the very early stage of the primary screening process
for developing the preparative separation of bioactive compounds. The simulation of preparative
separation based on the initial data from analytical-scale runs is not as accurate as simulation based
on the data from initial preparative-scale data. However, when high quality initial data are utilized
and when the columns at both scales are packed with as similar a phase material as possible,
especially the retention times given by up-scaled simulation are relatively close to reality. Therefore
it is often time saving to use the analytical runs as a basis for simulation of the preparative-scale
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separation. The inaccuracy in simulated peak widths caused by the increased sample load can be 
corrected in the simulation using a mathematical equation. In addition to the simulation of column
liquid chromatographic separations, the computer-assisted simulation program was also found to be
applicable for simulating reversed phase TLC separation when the initial data are obtained from
TLC separations. It was also concluded that transfer of the method from TLC to HPLC is possible
by means of DryLab. However, this requires relatively large amount of experiments in order to be
able to predict the separations to a reasonably accurate extent after the transfer procedure. Overall
the computer-assisted scaling-up of a separation method was found to require considerably less
experimental separations than the traditional trial-and-error scale-up procedure. Thus the time and
effort spent on the preparative separation method development can now be decreased remarkably by
using the procedure described in this study.
Coupling the HPLC microfractionation with the off-line microplate based bioactivity assays has
been found to enhance the primary screening process. In microfractionation, i.e. bioassay-scale 
fractionation, the complex sample is fractionated using analytical-scale gradient elution into
microtitre well plate. This means that, in addition to the fractions, the data from the HPLC run are 
also collected. The HPLC data can be further used to evaluate the sample, the data can serve as a 
base for further separation method development, and it may even be used for compound
identification. The use of HPLC permits the simultaneous use of advanced spectrometric devices
such as MS and NMR to carry out an in-depth structure elucidation during the fractionation process.
Microtitre well plates have proved to provide a valuable platform for different types of bioassays.
Biochemical-based and cell-based (both bacterial and mammalian cells) bioassays have also proved
to be suitable for use with the microfractionation procedure. Especially for cell-based bioassays,
which are nearly always unsuitable for use with on-line bioassays, this procedure offers a solution to 
enhance the efficiency and throughput. Distinct benefits obtained from the use of microplate-based
assays and analytical HPLC fractionations are the speed of the procedure, the small amount of
sample required, and convenient sample handling. However, the procedure has not been evolved for
determining the concentrations of individual compounds, which is often an inappropriate procedure
during the primary screening process.
In conclusion, this study has gathered the necessary pieces and information to build up and develop
at the laboratory scale a primary screening procedure from microfractionation, via an appropriate
bioassay, to the isolation of bioactive compounds using computer-assisted separation method
development.
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